News item
TGA extends exclusive use of new listed medicine ingredients from 2 to 3 years
We have extended the market exclusivity period for eligible new ingredients used in listed medicines from 2 to 3 years from 9 November 2026.
This is for Doceo members
Membership is free. Join in a minute, or log in if you’re already a member.
Latest news
-
Dip in complaints about AHPRA to health ombudsman
An annual review found investigations about more complex issues are on the rise, while gripes about registration declined. -
MRAC recommends lifting chronic care cap to 12 visits
It proposes more than doubling referred CCM visits and expanding access to group programs, amid concerns the current… -
More choice for older people paying for residential aged care
From 31 October, residents waiting for a means assessment for residential aged care can choose how they pay…
